- Investing Ideas
- /
- Swedish Biotech Breakthroughs
Swedish Biotech Breakthroughs
Results
12
Biotech stocks worldwide which are expected to become profitable in the next 3 years.
12 companies
Egetis Therapeutics
Market Cap: SEK 2.3b
A pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment.
EGTX
SEK 5.77
7D
-0.5%
1Y
26.7%
Biovica International
Market Cap: SEK 154.2m
A biotech company, develops and commercializes novel blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in the European Union, United States of America, and internationally.
BIOVIC B
SEK 0.56
7D
-5.1%
1Y
-74.4%
Guard Therapeutics International
Market Cap: SEK 463.9m
A pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden.
GUARD
SEK 23.00
7D
0.9%
1Y
1.8%
Xspray Pharma
Market Cap: SEK 1.1b
A pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden.
XSPRAY
SEK 26.10
7D
0.4%
1Y
-54.7%
Lipigon Pharmaceuticals
Market Cap: SEK 79.1m
Develops drugs for lipid related diseases in Sweden.
LPGO
SEK 0.13
7D
-9.1%
1Y
-32.0%
Xbrane Biopharma
Market Cap: SEK 230.8m
A biotechnology company, engages in the development, manufacture, and sale of biosimilars.
XBRANE
SEK 11.20
7D
-51.9%
1Y
-57.5%
Devyser Diagnostics
Market Cap: SEK 2.3b
Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.
DVYSR
SEK 135.20
7D
0.4%
1Y
6.0%
Diamyd Medical
Market Cap: SEK 1.5b
Develops precision medicine therapies for the treatment of autoimmune diabetes.
DMYD B
SEK 10.66
7D
0.8%
1Y
-17.6%
SynAct Pharma
Market Cap: SEK 1.2b
A clinical stage biotechnology company, researches and develops medicines for the treatment of inflammatory diseases in Sweden.
SYNACT
SEK 22.20
7D
2.1%
1Y
147.8%
BioInvent International
Market Cap: SEK 1.8b
A clinical-stage company, discovers and develops immuno-modulatory antibodies for the treatment of cancer in Sweden, Europe, the United States, and internationally.
BINV
SEK 27.80
7D
3.9%
1Y
-36.5%
Active Biotech
Market Cap: SEK 98.3m
A biotechnology company, engages in the research, development, and production of pharmaceutical products in Sweden.
ACTI
SEK 0.08
7D
-49.6%
1Y
-77.8%
Mendus
Market Cap: SEK 303.9m
A biopharmaceutical company, develops immunotherapies for the treatment of tumor recurrence and established tumors.
IMMU
SEK 5.99
7D
4.2%
1Y
-37.2%